scispace - formally typeset
E

E. Kiss

Researcher at Semmelweis University

Publications -  23
Citations -  925

E. Kiss is an academic researcher from Semmelweis University. The author has contributed to research in topics: Lupus erythematosus & Vitamin D and neurology. The author has an hindex of 7, co-authored 21 publications receiving 862 citations.

Papers
More filters

Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies). Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

Abstract: Objectives: To identify the main causes of morbidity and mortality in patients with antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and immunological parameters with prognostic significance. Methods: The clinical and immunological features of a cohort of 1000 patients with APS from 13 European countries who had been followed up from 1999 to 2004 were analysed. Results: 200 (20%) patients developed APS-related manifestations during the 5-year study period. Recurrent thrombotic events appeared in 166 (16.6%) patients and the most common were strokes (2.4% of the total cohort), transient ischaemic attacks (2.3%), deep vein thromboses (2.1%) and pulmonary embolism (2.1%). When the thrombotic events occurred, 90 patients were receiving oral anticoagulants and 49 were using aspirin. 31/420 (7.4%) patients receiving oral anticoagulants presented with haemorrhage. 3/121 (2.5%) women with only obstetric APS manifestations at the start of the study developed a new thrombotic event. A total of 77 women (9.4% of the female patients) had one or more pregnancies and 63 (81.8% of pregnant patients) had one or more live births. The most common fetal complications were early pregnancy loss (17.1% of pregnancies) and premature birth (35% of live births). 53 (5.3% of the total cohort) patients died. The most common causes of death were bacterial infection (21% of deaths), myocardial infarction (19%) and stroke (13%). No clinical or immunological predictor of thrombotic events, pregnancy morbidity or mortality was detected. Conclusion: Patients with APS still develop significant morbidity and mortality despite current treatment (oral anticoagulants or antiaggregants, or both).
Journal ArticleDOI

The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary.

TL;DR: The data suggest that vitamin D deficiency in SLE may play a role in perpetuation of the disease and serological and clinical parameters in patients with different vitamin D levels from a single centre registry in Central-Eastern Europe.
Journal ArticleDOI

The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.

TL;DR: Several cognitive functions measured by CANTAB are negatively influenced by hyperphenylalaninemia in adult PKU patients, however, response speed and initial thinking time were not impaired as seriously as other functions.